Reevaluating PSA testing rates in the PLCO trial

New England Journal of Medicine

Volumn 374, Issue 18, 2016, Pages 1795-1796

  Shoag, Jonathan E ^a   Mittal, Sameer ^a   Hu, Jim C ^b  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANTIGEN DETECTION; BLOOD ANALYSIS; CANCER SCREENING; CONTAMINATION; CONTROLLED STUDY; FOLLOW UP; HEALTH STATUS QUESTIONNAIRE; HEALTH SURVEY; HUMAN; LETTER; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE DISEASE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCREENING TEST; BLOOD; DIGITAL RECTAL EXAMINATION; EARLY CANCER DIAGNOSIS; ECONOMICS; PRACTICE GUIDELINE; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIAL (TOPIC); STANDARDS; UNITED STATES;

DIGITAL RECTAL EXAMINATION; EARLY DETECTION OF CANCER; HUMANS; MALE; PRACTICE GUIDELINES AS TOPIC; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; UNITED STATES;

EID: 84968779530     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1515131     Document Type: Letter

References (4)

1. Andriole GL, Crawford ED, Grubb RL III, et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 2009; 360: 1310-9.
2. Moyer VA. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2012; 157: 120-34.
3. Pinsky PF, Blacka A, Kramer BS, Miller A, Prorok PC, Berg C. Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. Clin Trials 2010; 7: 303-11.
4. Carter HB, Albertsen PC, Barry MJ, et al. Early detection of prostate cancer: AUA guideline. J Urol 2013; 190: 419-26.